| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
PLX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 320.0K | - | - | |
| COO | 112.0K | - | - | |
| Dir | 17.0K | - | - | |
| Dir | 17.0K | - | - | |
| Dir | 17.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Bashan Dror56 | President And CEO | Buy | 56,000 | $1.81 | $101,360.00 | +42.3% | +28.9% | - | |
| Nov 18, 2025 | Bar-Shalev Amos | Director | Sell | 168 | $1.87 | $314.16 | -100% | +58.5% | - | |
| Jun 10, 2025 | Schwartz Aharon | Director | Buy | 129,000 | $1.60 | $205,884.00 | +74.1% | 0.0% | +25.9% | |
| Oct 19, 2023 | Bashan Dror56 | President And CEO | Buy | 64,516 | $1.40 | $90,483.69 | +94.9% | +5.5% | -25.3% | |
| Jan 3, 2023 | Schwartz Aharon | Director | Buy | 110,000 | $1.42 | $155,815.00 | +171.9% | +61.3% | +30.7% | |
| Apr 11, 2022 | Bashan Dror56 | President And CEO | Buy | 68,000 | $1.50 | $102,000.00 | New | -21.6% | +66.7% | |
| Jun 3, 2021 | Dexcel Pharma Technologies Ltd.79 | 10% Owner | Sell | 918,717 | $2.27 | $2,088,857.27 | -20.2% | -28.4% | -44.1% | |
| Apr 7, 2020 | Schwartz Aharon | Director | Buy | 64,000 | $2.43 | $155,264.00 | New | - | - | |
| May 16, 2017 | Manor Moshe | President &CEO | Buy | 50,000 | $0.81 | $40,500.00 | New | - | - | |
| Dec 2, 2016 | Camber Capital Management LLC | 10% Owner | Sell | 2,500,000 | $0.32 | $792,000.00 | -18.8% | - | - |